Clinical Trial Update: Pilot Study Estradiol Followed by Exemestane Hormone Receptor + Metastatic Breast Cancer [NA]

View source ↗

Summary

Pilot study evaluating estradiol followed by exemestane in hormone receptor-positive metastatic breast cancer; trial completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Estrogen Receptor-positive Breast Cancer
• Progesterone Receptor-positive Tumor
• Stage Iiic Breast Cancer

Drugs mentioned

• ESTRADIOL (Estradiol)
• Exemestane (Exemestane)

Snippet

Sponsor: University of Arizona | Conditions: Estrogen Receptor-positive Breast Cancer, Progesterone Receptor Positive Tumor | NA | Status: COMPLETED | Results posted: 2018-10-17